BackNRX Pharmaceuticals- Warrants (24/05/2026) Overview

NRX Pharmaceuticals- Warrants (24/05/2026) Total Assets

Track NRX Pharmaceuticals- Warrants (24/05/2026)'s total assets ($34M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$34.16M
606.08% YoYΔ $29.32M vs prior year quarter

Peer trimmed avg / median

Loading

NRX Pharmaceuticals- Warrants (24/05/2026) Total Assets History

Loading

NRX Pharmaceuticals- Warrants (24/05/2026) vs. peers: Total Assets Comparison

Loading

NRX Pharmaceuticals- Warrants (24/05/2026) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NRX Pharmaceuticals- Warrants (24/05/2026) (NRXPW) FAQ

As of the most recent data (June 2026), NRXPW shows a total assets of $34M. That compares with $4.8M in the prior-year period — up 606.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRXPW's total assets is now $34M (was $4.8M) — a 606.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NRX Pharmaceuticals- Warrants (24/05/2026) is outperforming or lagging.

Tracking NRXPW's total assets over time shows whether NRX Pharmaceuticals- Warrants (24/05/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $34M That compares with $4.8M in the prior-year period — up 606.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has NRX Pharmaceuticals- Warrants (24/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $34M) with ownership activity and broader fundamentals.

NRX Pharmaceuticals- Warrants (24/05/2026)'s total assets is $34M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.